| Literature DB >> 34940890 |
U Krafft1, O Mahmoud2, J Hess2, J P Radtke2, A Panic2, L Püllen2, C Darr2, C Kesch2, T Szarvas2,3, C Rehme2, B A Hadaschik2, S Tschirdewahn2.
Abstract
PURPOSE: Ureteroenteric anastomosis after cystectomy is usually performed using the Bricker or Wallace technique. Deterioration of renal function is the most common long-term complication of urinary diversion (UD). To improve surgical care and optimize long-term renal function, we compared the Bricker and Wallace anastomotic techniques and identified risk factors for ureteroenteric strictures (UES) in patients after cystectomy.Entities:
Keywords: Bladder cancer; Bricker; Cystectomy; Urinary diversion; Wallace
Mesh:
Year: 2021 PMID: 34940890 PMCID: PMC9151556 DOI: 10.1007/s00423-021-02413-4
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 2.895
Preoperative and operative patient’s characteristics
| 132 | 134 | Renal units, | |
| 0.53 | 67.6 (9) | 66.6 (10.8) | Age (years), mean (SD) |
| 0.34 | 48 (72.7) | 55 (79.7) | Male gender, |
| 0.58 | 27 (4.4) | 26.7 (5.4) | BMI (kg/m2), mean (SD) |
| 0.03 | 1.2 (0.4) | 1 (0.4) | Preoperative serum creatinine (mg ∕dl), mean (SD) |
| 0.00 | 29 (43.9) | 15 (21.7) | GFR (ml/min/1.73 m2) < 60, |
| 0.26 | 11 (16.6) | 7 (10.1) | Diabetes, |
| 0.74 | 24 (36.3) | 27 (39.1) | Vascular disease, |
| 0.85 | 21(31.8) | 23 (33.3) | Smoking history, |
| 0.76 | 27 (40.9) | 30 (43.9) | ASA score ≥ 3, |
| 0.5 | 5 (7.6) 8 (12.1) | 9 (13) 8 (11.6) | Preoperative hydronephrosis, Unilateral Bilateral |
| 0.67 | 5 (7.5) | 4 (5.8) | Preoperative chemotherapy, |
| 0.26 | 6 (9.1) | 3 (4.3) | History of pelvic radiotherapy, |
| 0.7 | 9 (13.6) | 11 (15.9) | History of abdominal surgery, |
| 0.07 | 7 (10.9) 54 (81.8) 2 (3) 1 (1.5) 2 (3) | 1 (1.4) 66 (95.7) 2 (2.9) 0 0 | Indication for cystectomy, Benign disease Bladder cancer Prostate cancer Gynecologic cancer Colorectal cancer |
| 0.38 | 54 (81.8) 10 (15.1) 2(3) | 50 (72.4) 17 (24.6) 2 (2.9) | Diversion technique, Ileal conduit Orthotopic neobladder Continent cutaneous |
| 0.9 | 2 (3) | 2 (2.9) | Distant Metastasis, |
Pathology results of cystectomy specimens
| 0.32 | 1 (1.8) 14 (25.9) 13 (24) 17 (31.4) 9 (16.6) | 4 (6) 11 (16.6) 18 (27.2) 27 (40.9) 6 (9.09) | Tumor stage, T0 Ta, Tis, T1 T2 T3 T4 |
| 0.69 | 41 (75.9) 13 (24) | 48 (72.7) 18 (27.2) | Nodal stage, Nx/N0 N1-3 |
| 0.5 | 2 (1–10) | 1.5 (1–26) | No. positive lymph nodes, median (range) |
| 0.73 | 50 (92.6) 4 (7.4) | 62(93.9) 4 (6) | Histology, Urothelial carcinoma Non urothelial carcinoma |
Postoperative parameters in Bricker and Wallace group comparison
| 0.19 | 16 (6–58) | 14 (6–39) | Follow-up (months), median (range) |
| 0.00 | 1.2 (0.4) | 1 (0.2) | Postoperative serum creatinine (mg ∕dl), mean (SD) |
| 0.18 | 20 (30.3) | 13 (18.8) | 90-day Clavien grade ≥ III, |
| 0.04 | 8 (12.1) | 2 (2.9) | Urinary leakage, |
| 0.19 | 13 (19.7) | 8 (11.6) | UES, |
| < 0.001 | 22/132 (16.6) | 8/134 (5.9) | UES/renal units, |
| 0.3 | 3 (1–38) | 2.5 (1–16) | Median time to stricture, month (range) |
| 0.00 | 4 (30.8) 0 9 (69.2) | 6 (75) 2 (25) 0 | Stricture laterality, Left Right Bilateral |
Comparison between stricture and non-stricture groups
| Non-UES group | UES group | Variable | |
|---|---|---|---|
| 0.99 | 66.6 (9.6) | 69.9 (10) | Age (years), mean (SD) |
| 0.9 | 87 (76.3) | 16 (76.2) | Male gender, |
| 0.2 | 26.7 (4.6) | 28.2 (6.5) | BMI (kg/m2), mean (SD) |
| 0.1 | 1.1 (0.4) | 1.09 (0.18) | Preoperative serum creatinine (mg ∕dl), mean (SD) |
| 0.88 | 15 (13.1) | 3 (14.2) | Diabetes mellitus, |
| 0.34 | 45 (39.4) | 6 (28.5) | Cardiovascular disease, |
| 0.05 | 41(35.9) | 3 (14.2) | Smoking history, |
| 0.36 | 50 (43.8) | 7 (33.3) | ASA score ≥ 3, |
| 0.06 | 37 (15.7) | 9 (30) | Preoperative hydronephrosis/renal units, n (%) |
| 0.01 | 5 (4.3) | 4 (19) | Preoperative chemotherapy, |
| 0.12 | 6 (5.2) | 3 (14.2) | History of pelvic radiotherapy, |
| 0.55 | 16 (14) | 4 (19) | History of abdominal surgery, |
| 0.69 | 87 (76.3) 24 (21) 3 (2.6) | 17 (81) 3 (14.2) 1 (4.7) | Diversion technique, Ileal conduit Orthotopic neobladder Continent cutaneous |
| 0.3 | 26 (22.8) | 7 (33.3) | 90 day-Clavian grade ≥ III, |
| 0.61 | 9 (7.9) | 1 (4.7) | Urinary leakage, |
| 0.89 | 56 (49.1) | 10 (47.6) | Local advanced dis., |
| 0.27 | 30 (26.3) | 8 (38.1) | Node positive dis., |
Multivariate analysis for predictors of UES
| Adjusted | Variable | |
|---|---|---|
| 0.304 | 1.05 (0.95–1.15) | BMI |
| 0.004 | 9.74 (2–46.2) | preoperative chemotherapy |
| 0.012 | 4.01 (1.36–11.82) | 90-day Clavian grade ≥ III |
| 0.38 | 1.56 (0.56–4.31) | Anastomotic technique (Wallace vs Bricker) |